ArticleJournal of ophthalmic inflammation and infection2024
Subconjunctival dirofilariasis in a healthy subject: a case report.
Article in Journal of ophthalmic inflammation and infection, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ocular and orbital dirofilariasis: A case series from Sisak-Moslavina County.Helminthologia · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo report a case of subconjunctival dirofilariasis presenting as an inflammatory mass-like lesion in a healthy individual. CASE PRESENTATION: A 20-year-old male with a recent history of wildlife exposure in a rural village presented with an inflammatory subconjunctival mass in his left eye. The lesion was surgically excised, and histopathological examination confirmed the presence of an immature nematode of Dirofilaria immitis. The patient was treated with oral ivermectin for two weeks postoperatively. After two months, the lesion had almost completely resolved, and no recurrence was observed during the 6-month follow-up.
conclusionsGiven the rarity of ocular dirofilariasis and its diverse presentations in different ocular and adnexal structures, prompt and complete excision followed by meticulous histopathological evaluation is crucial to guide appropriate management and achieve favorable outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.